TICKERNERD
Menu
CLCLConsumer Defensive · Household & Personal Products

CL Stock Forecast: Colgate-Palmolive Co. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$92
−1.05% on the day

The 21 Wall Street analysts covering Colgate-Palmolive Co. hold a median 12-month price target of $101 — +9.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 95 of 100 as at 15 Aug 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$73.3B
Ticker Nerd rank
95 / 100
Median analyst target
$101
Analysts covering
21
Total return, dividends reinvested
1W
−1.4%
1M
+1.6%
YTD
+18.5%
1Y
+11.3%
From 52W high
−6.1%
From 52W low
+24.8%
$74
$98
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CL stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Colgate-Palmolive Co. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Aug 2026
95 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Issuance
97
Volatility
95
Quality
95
Accruals
88
Revisions
83
Momentum
70
Value
63
Growth
47
Size
4

Issuance (97): The share count has been shrinking and the company is not leaning on new borrowing.

Growth (47): Sales and profits are flat, shrinking, or growing more slowly than they were.

Size (4): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CL stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CL, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$70$80$90$100$110Oct 25Jan 26Apr 26Jul 26CLHigh $110Median $101Low $87

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says21 analysts
13 Buy8 Hold0 Sell
Low $87Median $101High $110

The green dot is the last close — the median target sits +9.3% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 9 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
3 Aug 2026Evercore ISI GroupMaintainsOutperform$100 → $101
3 Aug 2026JP MorganMaintainsOverweight$104 → $103
3 Aug 2026RBC CapitalMaintainsOutperform$102 → $104
3 Aug 2026TD CowenMaintainsHold$85 → $90
3 Aug 2026UBSMaintainsBuy$106 → $109
21 July 2026BarclaysMaintainsEqual-Weight—
21 July 2026BarclaysMaintainsEqual-Weight$80 → $87
16 July 2026JP MorganMaintainsOverweight—
16 July 2026JP MorganMaintainsOverweight$96 → $104
16 July 2026UBSMaintainsBuy$100 → $106
16 July 2026UBSMaintainsBuy—
14 July 2026CitigroupMaintainsBuy—
14 July 2026CitigroupMaintainsBuy$105 → $110
9 July 2026Piper SandlerMaintainsOverweight—
9 July 2026Piper SandlerMaintainsOverweight$92 → $96
8 July 2026Wells FargoMaintainsEqual-Weight—
11 June 2026BernsteinInitiatesMarket Perform—
5 May 2026BarclaysMaintainsEqual-Weight—
4 May 2026JP MorganMaintainsOverweight—
4 May 2026RBC CapitalReiteratesOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CL appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

CL analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+1.5%
Analysts raising
4
Analysts cutting
3
Fundamentals

Colgate-Palmolive Co. (CL) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
36.6×

Cheaper than 22% of US stocks

Price / sales
3.5×

Cheaper than 37% of US stocks

Price / book
310.6×

Cheaper than 1% of US stocks

EV / EBITDA
16.1×

Cheaper than 22% of US stocks

Growth & margins
Revenue growth (YoY)
4.9%

Higher than 39% of US stocks

Earnings growth (YoY)
−6.7%

Higher than 28% of US stocks

Gross margin
61.5%

Higher than 75% of US stocks

Operating margin
21.0%

Higher than 80% of US stocks

Net margin
9.7%

Higher than 69% of US stocks

Returns & dividend
Return on equity
267.4%

Higher than 99% of US stocks

Return on assets
15.8%

Higher than 98% of US stocks

Dividend yield
2.3%

Higher than 52% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

CL vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHousehold & Personal Products
CompanyMarket capTKN rank
CLColgate-Palmolive Co.$73.3B
95
KVUEKenvue, Inc.$36.9B
65
KMBKimberly-Clark Corp.$36.6B
63
ELThe Estée Lauder Companies, Inc.$30.1B
71
CHDChurch & Dwight Co., Inc.$24.7B
67
PGProcter & Gamble Co.$336.6B
60
CLXThe Clorox Co.$12.9B
27

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Colgate-Palmolive Co. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CL news & analysis

5 Dividend Kings to Buy and Hold Forever in August

24/7 Wall Street · 14 Aug 2026positive

An article titled "5 Dividend Kings to Buy and Hold Forever in August" highlights Dividend Kings — companies with at least 50 consecutive years of dividend increases — describing them as the backbone of any buy-and-hold income portfolio. The piece presents these companies in a favorable context for long-term income-focused investors.

Why it matters — Colgate-Palmolive is widely recognized as a Dividend King, so its inclusion in a group lauded for consistent long-term dividend growth reflects positively on the company's track record.

BJ or CL: Which Is the Better Value Stock Right Now?

Zacks Investment Research · 12 Aug 2026neutral

Zacks Investment Research published a piece comparing BJ's Wholesale Club (BJ) and Colgate-Palmolive (CL) for investors seeking undervalued Consumer Products - Staples stocks. The article examines which of the two companies offers the better value option.

Why it matters — The article places Colgate-Palmolive in the context of the value-stock discussion among consumer staples peers, which CL watchers would find relevant to their investment perspective.

4 Consumer Staples Stocks to Watch Amid Ongoing Industry Pressures

Zacks Investment Research · 12 Aug 2026positive

Zacks Investment Research identified Colgate-Palmolive (CL), along with KMB, CHD and BJ, as consumer staples stocks to watch. Despite ongoing cost pressures and spending volatility, the report notes these companies are using strategic initiatives and operational efficiencies to drive growth.

Why it matters — For CL watchers, the report highlights that Colgate-Palmolive is actively leveraging strategic initiatives and operational efficiencies to sustain growth amid industry-wide cost pressures and demand volatility.

Here's Why Colgate-Palmolive (CL) is a Strong Momentum Stock

Zacks Investment Research · 12 Aug 2026positive

Zacks Investment Research highlighted Colgate-Palmolive (CL) as a strong momentum stock, pointing to its Zacks Style Scores as a tool for identifying market-beating stocks. The piece frames CL as one of the stocks worth considering through this screening approach.

Why it matters — A CL watcher would care because the article positions the company favorably among momentum-focused investment screens, indicating positive recognition of its stock characteristics.

What to Know About Colgate-Palmolive Director John Cahill Selling 4,170 Shares for $389,353

The Motley Fool · 9 Aug 2026neutral

Colgate-Palmolive director John Cahill sold 4,170 shares on Aug. 6, 2026, realizing approximately $389,353 in transaction value. The sale reduced his total equity holdings by 6%, including shares from option exercise, and by 13% of his direct ownership.

Why it matters — A director's share sale that trims his holdings by a notable percentage is worth watching for Colgate-Palmolive investors as insider activity can signal sentiment among company leadership.

FAQ

Frequently asked questions about CL stock

What is the CL stock price forecast for 2026-2027?

The 21 Wall Street analysts covering Colgate-Palmolive Co. have a median 12-month price target of $101, with estimates ranging from $87 to $110. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CL stock a buy right now?

Of the 21 analysts covering Colgate-Palmolive Co., 13 rate it a Buy, 8 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Colgate-Palmolive Co. 95 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CL?

As at 15 Aug 2026, Colgate-Palmolive Co. ranks 95 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (97 of 100).

Will CL stock go up?

No one can know that. What the data says: the median 12-month target from 21 analysts implies +9.3% from the last close, and Ticker Nerd's factor model ranks Colgate-Palmolive Co. 95 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CL stock forecast for 2030?

No analyst covering Colgate-Palmolive Co. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CL are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $87 to $110 over the next 12 months.

How has CL stock performed over the past year?

Colgate-Palmolive Co. returned +11.3% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Colgate-Palmolive Co. do?

Colgate-Palmolive Company is an American multinational consumer products company. It focuses on the production and distribution of oral care, personal care, home care, and pet nutrition products for consumers worldwide.

What is the latest news on CL?

The most recent item we track (24/7 Wall Street, 14 Aug 2026): "5 Dividend Kings to Buy and Hold Forever in August". An article titled "5 Dividend Kings to Buy and Hold Forever in August" highlights Dividend Kings — companies with at least 50 consecutive years of dividend increases — describing them as the backbone of any buy-and-hold income portfolio. The piece presents these companies in a favorable context for long-term income-focused investors.

Company

About Colgate-Palmolive Co.

Colgate-Palmolive Company is an American multinational consumer products company. It focuses on the production and distribution of oral care, personal care, home care, and pet nutrition products for consumers worldwide. In oral care, Colgate-Palmolive offers toothpaste, toothbrushes, mouthwashes, and professional dental products under well-known global brands such as Colgate, Darlie, elmex, hello, meridol, Sorriso, and Tom’s of Maine. Its personal and home care portfolio includes liquid and bar soaps, shower gels, shampoos, conditioners, deodorants, dishwashing liquids, household cleaners, fabric conditioners, and skin health products marketed under brands like Palmolive, Softsoap, Irish Spring, Speed Stick, Ajax, Fabuloso, Murphy, Protex, Sanex, Soupline, and Suavitel. Through Hill’s Science Diet and Hill’s Prescription Diet, the company provides specialized pet nutrition products distributed via pet retailers, veterinarians, and e-commerce platforms. Headquartered in New York City, Colgate-Palmolive serves more than 200 countries and territories, playing a central role in the global consumer staples sector with extensive retail, wholesale, veterinary, and online distribution networks.

CEO Mr. Noel R. Wallace · 33,600 employees · United States · https://www.colgatepalmolive.com